Author

Meghan Fajardo

Institution: Pfizer (United States)

Observed institution: Pfizer (United States)

OpenAlex ID: A5117063254

Migraine in the workplace: Work productivity impact in a large US ‐based healthcare system using a cross‐sectional employee survey

2025 · Olivia Begasse de Dhaem, Allison Verhaak, et al. · Headache The Journal of Head and Face Pain · 3

Real‐world diagnosis and treatment of individuals with migraine in the United States: The Migraine Insights in Diagnosis and Treatment ( MIND ) study

2026 · Fred Cohen, Vincent Martin, et al. · Headache The Journal of Head and Face Pain

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Adults of Hispanic or Latino Ethnicity: Post Hoc Analysis of Three Randomized, Placebo-Controlled Trials

2026 · Julio R. Vieira, Meghan Fajardo, et al. · Neurology and Therapy

Sex differences in the real-world use of rimegepant for short-term prevention of migraine in the United States

2026 · Teshamae Monteith, Jessica Cirillo, et al. · Frontiers in Neurology

First Medications Prescribed for Acute Treatment or Prevention of Migraine Among Newly Diagnosed Adult Patients in the US: A Comparison of Neurologists vs. Primary Care Providers (P9-15.008)

2026 · Fred CohenA, Vincent Martin, et al. · Neurology

Understanding Real-world Perspectives of Healthcare Providers on Short-term Prevention for Migraine and Rimegepant Treatment Use by Patients: Findings from Cross-sectional Surveys (P8-15.017)

2026 · Teshamae Monteith, Jessica Ailani, et al. · Neurology

Real-world Effectiveness of Preventive Rimegepant: Longitudinal Outcomes Across Extended Follow-up Intervals (P10-15.020)

2026 · Phillip Phan, Scott Keith, et al. · Neurology

The Emerging Role of Digital Opinion Leaders in the Migraine Social Media Landscape (S35.010)

2025 · Teshamae Monteith, Monica Verduzco-Gutierrez, et al. · Neurology

Works count: 8

Citation count: 3

H-index: 1

I10-index: